Elevated herpesvirus-directed responses and antiflagellin antibodies seen up to 10 years prediagnosis in Crohn disease ...

Despite noting the high unmet need in Duchenne muscular dystrophy, the FDA panel concluded that trial data lacked substantial evidence of the therapy's effectiveness.

A dose-escalation study in 24 healthy adults showed that an 810mL infusion produced results comparable to fresh frozen plasma without significant safety signals. The Food and Drug Administration (FDA) ...

Gywn Lo demonstrated high contraceptive efficacy (Pearl Index 4.14), progressive cycle control, and excellent patch adhesion across diverse real-world conditions. The Food and Drug Administration (FDA ...

As number of risk factors increased, increase was seen in number of plaques and plaques with vulnerable phenotype.

There was an increase in the proportion of exclusive GLP-1 RA use from 88.2% in May to November 2022 to 96.1% from June 2025 to January 2026. HealthDay News — Adolescents and young adults are ...

PLEX100, an investigational prolonged-release local doxycycline product aimed at reducing surgical site infections in patients undergoing abdominal colorectal surgery.

Shionogi’s oral main protease inhibitor Xocova (ensitrelvir) is now available in the US to reduce the risk of symptomatic ...

Following an August 2025 CRL that raised no safety or manufacturing concerns, Saol provided additional survival analyses of existing clinical data to address FDA requirements without embarking on a ...

HealthDay News — Exposure to per- and polyfluoroalkyl substances (PFAS), or “forever chemicals,” during pregnancy and early life is associated with increased intestinal inflammation during childhood, ...